InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,353.20
(
-0.32%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.08
(
-0.65%
)
Bitcoin
63,695.28
(
-0.89%
)
Post# of 253213
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Johnny_C

Send PM Follow Ignore
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Johnny_C

Re: DewDiligence post# 217307

Thursday, 02/15/2018 9:56:29 AM

Thursday, February 15, 2018 9:56:29 AM

Post# of 253213
Sure, and they still think the drug has blockbuster potential. But BMY represents massive sales, Eliqius growth and their oncology lineup...They also have one state of the art new Biologic facility recently opened in Boston and they are constructing another one in Ireland.

Biolgics will create the longer streams of revenue post patent expiry.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up